Shree Surya Surgi Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 16-11-2024
- Paid Up Capital ₹ 0.23 M
as on 16-11-2024
- Company Age 14 Year,
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 16-11-2024
- Satisfied Charges ₹ 4.00 M
as on 16-11-2024
- Revenue 4.51%
(FY 2023)
- Profit 8.29%
(FY 2023)
- Ebitda -34.85%
(FY 2023)
- Net Worth 1.09%
(FY 2023)
- Total Assets -27.83%
(FY 2023)
About Shree Surya Surgi Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.23 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vikrant Suryawanshi, Ratnakar Tukaram, and Kishor Bagde serve as directors at the Company.
- CIN/LLPIN
U33111MH2010PTC211320
- Company No.
211320
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Shree Surya Surgi Pharma Private Limited offer?
Shree Surya Surgi Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Injectable Products, Anti Infective Drugs & Medicines, Remdesivir Injection, Anti Cancer Medicines, Arimidex Tablets, Cardiovascular Drugs & Medication, Cardiac Drugs, Oncology Drug.
Who are the key members and board of directors at Shree Surya Surgi Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishor Bagde  | Director | 10-Nov-2012 | Current |
| Vikrant Suryawanshi | Director | 23-Dec-2010 | Current |
| Ratnakar Tukaram | Director | 23-Dec-2010 | Current |
Financial Performance of Shree Surya Surgi Pharma.
Shree Surya Surgi Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.51% increase. The company also saw a slight improvement in profitability, with a 8.29% increase in profit. The company's net worth moved up by a moderate rise of 1.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Surya Surgi Pharma?
In 2023, Shree Surya Surgi Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shreesurya Pharma Private LimitedActive 8 years 9 monthsVikrant Suryawanshi and Ratnakar Tukaram are mutual person
Nexreet Ceutics Private LimitedActive 3 years 1 monthVikrant Suryawanshi and Ratnakar Tukaram are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Jul 2022 | ₹5.00 M | Open |
Others Creation Date: 10 May 2012 | ₹4.00 M | Satisfied |
How Many Employees Work at Shree Surya Surgi Pharma?
Unlock and access historical data on people associated with Shree Surya Surgi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Surya Surgi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Surya Surgi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
